Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Opioid Sparing Analgesic Strategies for TKA
NCT03954379Phase 4Completed
- Sponsor
- University Health Network
- Start
- Oct 2019
- Primary completion
- Dec 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of dexmedetomidine and ketamine in postoperative pain (2 arms), sponsored by University Health Network. Primary endpoint: Postoperative Opioid Consumption at 24 hours. Started Oct 2019; status: completed.
02
Drugs
dexmedetomidineketamine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT03954379.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03954379.